Log in or Sign up for Free to view tailored content for your specialty!
Pancreatic Disorders News
DP-b99 promising for acute high-risk pancreatitis
Results from a phase 2 pilot study showed DP-b99 was safe and well-tolerated in patients with acute high-risk pancreatitis and may lower inflammatory markers, the manufacturer announced.
Preop EUS-FNA does not increase mortality risk in resected pancreatic cancer
Preoperative endoscopic ultrasound-guided fine needle aspiration was not associated with worse survival in patients with resected pancreatic cancer and instead pointed to “improved outcomes,” according to recent study data.
Log in or Sign up for Free to view tailored content for your specialty!
NSAIDs useful for prevention of pancreatitis after ERCP
Clinical use of rectal NSAIDs were found to be appropriate for pharmacoprevention of pancreatitis following endoscopic retrograde cholangiopancreatography, according to results from a systematic review and meta-analysis.
Nut consumption associated with reduced risk for colorectal, pancreatic, endometrial cancers
Nut consumption was associated with lowered risk for developing colorectal, pancreatic and endometrial cancer, but similar associations were not observed for other cancers or type 2 diabetes, according to results from a new systematic review and meta-analysis.
Rapid growth rates of pancreatic cyst BD-IPMNs can predict malignancy
WASHINGTON — If a branch duct-intraductal papillary mucinous neoplasm grows at a rate of 2 mm or more annually or 10 mm or more overall, it should be considered a “worrisome feature” possibly predicting transformation into a malignancy, according to study findings.
Exposure to immunosuppressants has no effect on mucinous pancreatic cystic lesions
WASHINGTON — Patients with mucinous pancreatic cystic lesions have no clinically significant difference in the increasing of cyst size, the rate of progression to meet criteria for resection or their malignancy even if they have been exposed to immunosuppressive medications, according to a retrospective study presented at Digestive Disease Week.
FDA grants fast track designation to evofosfamide for advanced pancreatic cancer
The FDA has granted fast track designation for the development of evofosfamide for the treatment of metastatic or locally advanced unresectable pancreatic cancer in patients who were previously untreated, the manufacturer announced today.
Researchers identify risk factors for development of pancreatic cancer
A team of international researchers developed a profile identifying risk factors for malignancy progression in intraductal papillary mucinous neoplasms of the pancreas.
AGA guideline recommends change in diagnosis, management of asymptomatic pancreatic cysts
The American Gastroenterological Association has released a new guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts, which recommends some significant changes regarding surveillance periods and surgery.
Pain patterns, severity independent of abdominal imaging findings in chronic pancreatitis patients
Patterns and severity of pain associated with chronic pancreatitis were found to be independent of structural features observed with abdominal imaging in a recent study.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read